{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:58:43Z","timestamp":1790279923711,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Synovial sarcoma (SS) mostly arises in the extremities, yet data focused exclusively on primary extremity tumors remain limited. Therefore, we evaluated survival outcomes in patients with localized extremity SS treated at a large sarcoma referral center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective chart review of patients diagnosed with primary extremity SS between 2000 and 2020 with localized disease was conducted. Overall survival (OS), local recurrence-free survival (LRFS), and metastasis-free survival (MFS) were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study included 287 patients (median age: 35\u00a0y; follow-up: 5.3\u00a0y). Most tumors arose in the lower extremity (75%), and the median tumor size was 6\u00a0cm (range: 0.4 to 24). The median OS was 14 years, with a 10-year OS of 57%. Ten-year LRFS was 76%, and 10-year MFS was 51%. Tumors \u22655\u00a0cm (aHR: 2.06, 95% CI: 1.12-3.79), and the poorly differentiated subtype (aHR: 1.93, 95% CI: 1.01-3.69) were associated with inferior OS. For LRFS, positive\/unknown margins were strongly associated with elevated local-recurrence risk (aHR: 4.09, 95% CI: 2.30-7.28), whereas perioperative radiation therapy significantly improved LRFS (aHR: 0.38, 95% CI: 0.22-0.68). For MFS, in a subgroup of patients with tumors \u22654\u00a0cm, perioperative chemotherapy was independently associated with improved MFS (aHR: 0.54, 95% CI: 0.34-0.86).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Outcomes in extremity SS are driven by tumor size, subtype, and margin status. Perioperative radiation is recommended as it is associated with superior local control, and perioperative chemotherapy is highly recommended, particularly in patients with a tumor size of \u22654\u00a0cm, as it is associated with improved MFS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/coc.0000000000001374","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:00:10Z","timestamp":1790276410000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Primary Synovial Sarcoma of the Extremities Benefits From Perioperative Radiation and Chemotherapy"],"prefix":"10.1097","author":[{"given":"Riddhi R.","family":"Patel","sequence":"first","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Feit","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Werling","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora M.","family":"White","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Perez","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick P.","family":"Lin","sequence":"additional","affiliation":[{"name":"Orthopedic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul F.","family":"Valenzuela Perez","sequence":"additional","affiliation":[{"name":"Musculoskeletal Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Lazar","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyaskumar R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Ravi","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Livingston","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Zarzour","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Conley","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hromas","sequence":"additional","affiliation":[{"name":"Department of Medicine and the Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Somaiah","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejka M.","family":"Araujo","sequence":"additional","affiliation":[{"name":"Sarcoma Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"R1-20260924","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.anndiagpath.2014.09.002","article-title":"Synovial sarcoma: defining features and diagnostic evolution","volume":"18","author":"Thway","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"R2-20260924","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1038\/sj.onc.1204601","article-title":"Fusions of the SYT and SSX genes in synovial sarcoma","volume":"20","author":"Ladanyi","year":"2001","journal-title":"Oncogene"},{"key":"R3-20260924","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"J Clin Oncol"},{"key":"R4-20260924","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/cncr.24424","article-title":"Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients","volume":"115","author":"Sultan","year":"2009","journal-title":"Cancer"},{"key":"R5-20260924","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00003086-200402000-00025","article-title":"Synovial sarcoma: the importance of size and location for survival","volume":"419","author":"Deshmukh","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"R6-20260924","first-page":"1577","article-title":"Synovial sarcoma of the extremities and trunk: a long-lasting disease","volume":"18","author":"Gofman","year":"2007","journal-title":"Oncol Rep"},{"key":"R7-20260924","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2001.19.2.525","article-title":"Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients","volume":"19","author":"Trassard","year":"2001","journal-title":"J Clin Oncol"},{"key":"R8-20260924","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1002\/cncr.24370","article-title":"Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution","volume":"115","author":"Palmerini","year":"2009","journal-title":"Cancer"},{"key":"R9-20260924","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.clon.2024.01.018","article-title":"Clinicopathological profile and survival outcomes in patients with localised extremity synovial sarcomas","volume":"36","author":"Sharma","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R10-20260924","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1743-7563.2012.01563.x","article-title":"Prognostic factors and clinical outcomes in synovial sarcoma of the extremities","volume":"9","author":"Wisanuyotin","year":"2013","journal-title":"Asia Pac J Clin Oncol"},{"key":"R11-20260924","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1200\/JCO.2000.18.10.2087","article-title":"Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity","volume":"18","author":"Lewis","year":"2000","journal-title":"J Clin Oncol"},{"key":"R12-20260924","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.sla.0000262787.88639.2b","article-title":"Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma","volume":"246","author":"Eilber","year":"2007","journal-title":"Ann Surg"},{"key":"R14-20260924","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/SLA.0000000000006098","article-title":"New sarculator prognostic nomograms for patients with primary retroperitoneal sarcoma: case volume does matter","volume":"279","author":"Callegaro","year":"2024","journal-title":"Ann Surg"},{"key":"R15-20260924","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.3390\/cancers16234119","article-title":"Oncologic outcomes in patients with localized, primary head and neck synovial sarcoma","volume":"16","author":"Patel","year":"2024","journal-title":"Cancers"},{"key":"R16-20260924","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/cancers17050745","article-title":"Primary intrathoracic synovial sarcoma: an analysis of outcomes of this rare disease","volume":"17","author":"Patel","year":"2025","journal-title":"Cancers"},{"key":"R17-20260924","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/COC.0000000000001267","article-title":"Primary synovial sarcoma of the abdomen and pelvis","volume":"49","author":"Patel","year":"2025","journal-title":"Am J Clin Oncol"},{"key":"R18-20260924","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/COC.0000000000000822","article-title":"Synovial sarcoma of the hand and foot: an institutional review","volume":"44","author":"Patel","year":"2021","journal-title":"Am J Clin Oncol"},{"key":"R19-20260924","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jss.2020.05.075","article-title":"Radiotherapy is associated with improved survival in patients with synovial sarcoma undergoing surgery: a national cancer database analysis","volume":"255","author":"Gingrich","year":"2020","journal-title":"J Surg Res"},{"key":"R20-20260924","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jso.23780","article-title":"Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: a SEER analysis","volume":"111","author":"Naing","year":"2015","journal-title":"J Surg Oncol"},{"key":"R21-20260924","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/COC.0000000000000148","article-title":"Effects of adjuvant radiotherapy in patients with synovial sarcoma","volume":"40","author":"Song","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"R22-20260924","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.3390\/app11167407","article-title":"Synovial sarcoma of the extremities: a literature review","volume":"11","author":"Faur","year":"2021","journal-title":"Appl Sci"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0000000000001374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:00:13Z","timestamp":1790276413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0000000000001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000001374","relation":{},"ISSN":["0277-3732","1537-453X"],"issn-type":[{"value":"0277-3732","type":"print"},{"value":"1537-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"2026-06-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}